Kincell Bio

Research Triangle Park, NC
No confirmed program data — ClinicalTrials.gov verification pending · Last scored 2026-09-07
56.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (7) ○ EMA GMP ○ MHRA GMP

Quick Facts: Kincell Bio

Signal Score
56.5/100 (as of 2026-09-07)
Quality Compliance
Assessment pending
Headquarters
Research Triangle Park, NC
Modalities
Cell Therapy
Active Programs
Data pending
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Kincell Bio

Cell therapy CDMO in Wisconsin.

Signal Score & Pillar Breakdown

Scores are being republished. Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity 53.0
Profile-based capacity assessment
Recent Press7 articles

Recent News 7 articles

facility_expansion 2026-04-15
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - BioSpace
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  BioSpace
facility_expansion 2026-04-14
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Business Wire
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  Business Wire
facility_expansion 2026-04-14
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Voice of Alexandria
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  Voice of Alexandria
general 2026-04-14
Kincell Bio Expands Research Triangle Park, North Carolina Facility - Contract Pharma
Kincell Bio Expands Research Triangle Park, North Carolina Facility  Contract Pharma
facility_expansion 2026-04-14
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Times Argus
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  Times Argus
facility_expansion 2026-04-14
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - News-Press NOW
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  News-Press NOW
facility_expansion 2026-04-14
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Yahoo Finance
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs  Yahoo Finance

Frequently Asked Questions About Kincell Bio

What is Kincell Bio's CDMO Signal Score?
Kincell Bio has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Kincell Bio for a manufacturing program?
Use the free AI matchmaker to compare Kincell Bio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
bluebird bio Manufacturing
Durham, NC
Signal Score: 78.5
Lentiviral, Cell Therapy
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 74.5
mRNA, Gene Therapy, Cell Therapy, Lentiviral
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 91.1
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.9
CAR-T, Cell Therapy